Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by themagicboxon Feb 06, 2020 11:57am

167 Views

Post# 30652318

RE:RE:RE:FE announcement in March

Have to factor that data processing. But again multiple sites are confirmed to be recruiting till end of feb (which does not include overenrolment).

And 5 weeks to process the data. While dont think a delay will happen till for FE, I think a delay will happen for results.

Like Dan said, 2-3 months from mid Jan. ATE is known to miss every deadline (and the new deadline after tha). This study has been delayed 3 times now.

MUGMODs wrote: Yes ... somewhere between Jan 17 - 20, he said it three different times in that podcast.

First he said ...
"In 2 to 3 months we will be a phase 3 company."
then he said ...
"In 2 to 3 months we will have our big data readout."
and finally, he said ...
"We will start partnering activity in 3 months."

He left himself a lot of wiggle room but It still makes sense that FE would happen in Q1 - unless we hear otherwise.